London: In a new study, scientists have revealed that they are a step closer to curing diabetes after discovering how a potent two-pronged attack on diabetes can wipe it out.
Researchers of the study found that a powerful “combination therapy” can tackle the condition, even at a late stage.
Around 370,000 Britons have Type 1 diabetes, which develops when immune cells in the body attack and destroy beta cells in the pancreas leaving it unable to produce insulin, the hormone which controls blood sugar levels.
The researchers in California found they can reverse the process by quickly shutting down this “autoimmune” attack on beta cells before feeding the pancreas growth factor molecules.
However, tests have been carried out only on mice.
“The findings hint that people with late-stage diabetes could potentially be cured with a mix of two techniques that spur re-growth of pancreatic cells while stopping autoimmunity,” the Daily Express quoted the researchers as saying.
Type 1 diabetes can develop at any age but usually appears before the patient is 40, especially in childhood.
It is important that laboratory-based research like this is conducted, and that it is followed up, but the many years and many obstacles which lie between this point and any possible use in people mean that we should not get too excited at this stage
The study by a team at the Beckman Research Institute of City of Hope in Duarte, California showed the combination treatment lets new beta cells fully regenerate and produce insulin without a risk of being depleted by the immune system.
The researchers said that more studies are needed to see if the technique can work on humans.
“This paper provides insight into techniques which may be used in combination to regenerate and protect insulin producing beta cells,” Matthew Hobbs, head of research for Diabetes UK, said.
“However, it is extremely important to realise that these two techniques have so far only been tested in mice, either individually or in combination.
“It is important that laboratory-based research like this is conducted, and that it is followed up, but the many years and many obstacles which lie between this point and any possible use in people mean that we should not get too excited at this stage. Certainly, it is far too early to hail this as a cure for Type 1 diabetes,” he added.
The study has been published in the journal Science Translational Medicine.
ANI
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookies Setting
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device and the processing of information obtained via those cookies (including about your preferences, device and online activity) by us and our commercial partners to enhance site navigation, personalise ads, analyze site usage, and assist in our marketing efforts. More information can be found in our Cookies and Privacy Policy. You can amend your cookie settings to reject non-essential cookies by clicking Cookie Settings below.
Manage Consent Preferences
Strictly Necessary Cookies
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work or you may not be able to login.
Functional Cookies
These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.
Targeting Cookies
These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They are also used to limit the number of times you see an advert as well as help measure the effectiveness of an advertising campaign. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.
Performance Cookies
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we may not know when you have visited our site, and may not be able to monitor its performance.